AllStripes

📍 San Francisco, United States🗓 Founded 2017👥 16 employees💰 Last funded Nov 2019
Biotechnology Research🌐 allstripes.com
Website LinkedIn
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors. For more information, visit www.allstripes.com.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in AllStripes?
AllStripes has 2 investors on record on gritt.io, including 2 early-stage backers.
When did AllStripes last raise funding?
The most recent investment in AllStripes recorded on gritt.io was in November 2019.
When was AllStripes founded?
AllStripes was founded in 2017.
What industry is AllStripes in?
AllStripes operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AllStripes based?
AllStripes is headquartered in San Francisco, United States.